Ha habido 50 transacciones internas recientes registradas para Allogene Therapeutics, Inc. (ALLO), incluyendo 25 compras y 24 ventas. El total de compras internas fue valorado en $11.74M y el total de ventas internas en $910.29K.
Internos destacados con actividad reciente incluyen Beneski Benjamin Machinas, Chang David D, Belldegrun Arie. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ALLO
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-31 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Venta Informativa |
2,867 |
$2.50 |
$7.17K |
195,338 |
| 2026-03-16 |
Chang David D |
President and CEO |
Venta Informativa |
47,763 |
$2.47 |
$117.97K |
5,150,599 |
| 2026-03-16 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Venta Informativa |
4,835 |
$2.47 |
$11.94K |
198,205 |
| 2026-03-02 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Venta Informativa |
7,132 |
$2.60 |
$18.54K |
203,040 |
| 2026-02-02 |
Belldegrun Arie |
Director |
Concesión de RSU |
263,033 |
- |
- |
263,033 |
| 2026-02-02 |
Douglas Earl Martin |
SVP, General Counsel |
Concesión de RSU |
152,480 |
- |
- |
152,480 |
| 2026-02-02 |
Parker Geoffrey M. |
Chief Financial Officer |
Concesión de RSU |
152,480 |
- |
- |
152,480 |
| 2026-02-02 |
Chang David D |
President and CEO |
Concesión de RSU |
392,586 |
- |
- |
392,586 |
| 2026-02-02 |
Yoshiyama Annie |
SVP, Finance |
Concesión de RSU |
50,827 |
- |
- |
50,827 |
| 2026-02-02 |
Roberts Zachary |
EVP of R&d |
Concesión de RSU |
203,307 |
- |
- |
203,307 |
| 2026-02-02 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Concesión de RSU |
105,720 |
- |
- |
105,720 |
| 2026-01-21 |
Roberts Zachary |
EVP of R&d |
Venta Informativa |
26,269 |
$1.56 |
$40.98K |
616,866 |
| 2025-12-18 |
Kazam Joshua A |
Director |
Ejercicio de Opciones (Venta) |
47,700 |
- |
- |
47,700 |
| 2025-11-17 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Venta Informativa |
786 |
$1.22 |
$958.92 |
217,721 |
| 2025-10-21 |
Parker Geoffrey M. |
Chief Financial Officer |
Venta Informativa |
36,744 |
$1.26 |
$46.17K |
1,276,796 |
| 2025-06-18 |
Sato Vicki L |
Director |
Concesión de RSU |
144,400 |
$1.29 |
$186.28K |
144,400 |
| 2025-06-18 |
Kazam Joshua A |
Director |
Concesión de RSU |
94,500 |
- |
- |
94,500 |
| 2025-06-18 |
Humer Franz B |
Director |
Concesión de RSU |
95,400 |
- |
- |
95,400 |
| 2025-06-18 |
Witte Owen N. |
Director |
Concesión de RSU |
95,400 |
- |
- |
95,400 |
| 2025-06-18 |
Messemer Deborah M. |
Director |
Concesión de RSU |
95,400 |
- |
- |
95,400 |
| 2025-06-18 |
Barrett Elizabeth A. |
Director |
Concesión de RSU |
95,400 |
- |
- |
95,400 |
| 2025-06-18 |
Mayo Stephen |
Director |
Concesión de RSU |
95,400 |
- |
- |
95,400 |
| 2025-06-10 |
Messemer Deborah M. |
Director |
Venta Informativa |
36,885 |
$1.42 |
$52.38K |
107,431 |
| 2025-04-21 |
Yoshiyama Annie |
SVP, Finance |
Venta Informativa |
9,601 |
$1.41 |
$13.54K |
130,663 |
| 2025-03-14 |
Chang David D |
President and CEO |
Venta Informativa |
46,668 |
$1.96 |
$91.47K |
5,276,569 |
| 2025-03-14 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Venta Informativa |
5,488 |
$1.98 |
$10.84K |
218,507 |
| 2025-03-01 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Desconocido |
9,014 |
$9.69 |
$87.35K |
- |
| 2025-03-01 |
Beneski Benjamin Machinas |
SVP, Chief Technical Officer |
Concesión de RSU |
112,339 |
$1.80 |
$202.21K |
112,339 |
| 2025-02-18 |
Messemer Deborah M. |
Director |
Venta Informativa |
13,313 |
$2.43 |
$32.35K |
144,316 |
| 2025-02-03 |
Douglas Earl Martin |
SVP, General Counsel |
Venta Informativa |
6,404 |
$1.71 |
$10.95K |
587,848 |
| 2025-02-03 |
Parker Geoffrey M. |
Chief Financial Officer |
Venta Informativa |
4,361 |
$1.73 |
$7.54K |
1,301,540 |
| 2025-02-03 |
Chang David D |
President and CEO |
Venta Informativa |
46,003 |
$1.68 |
$77.29K |
5,317,237 |
| 2025-02-03 |
Moore Timothy L. |
Chief Technical Officer |
Venta Informativa |
14,746 |
$1.71 |
$25.22K |
250,713 |
| 2025-02-03 |
Roberts Zachary |
EVP of R&d |
Venta Informativa |
18,832 |
$1.70 |
$32.01K |
643,135 |
| 2025-01-24 |
Belldegrun Arie |
Director |
Concesión de RSU |
1,307,927 |
$1.94 |
$2.54M |
1,307,927 |
| 2025-01-24 |
Douglas Earl Martin |
SVP, General Counsel |
Concesión de RSU |
512,370 |
$1.94 |
$994K |
512,370 |
| 2025-01-24 |
Parker Geoffrey M. |
Chief Financial Officer |
Concesión de RSU |
614,844 |
$1.94 |
$1.19M |
614,844 |
| 2025-01-24 |
Chang David D |
President and CEO |
Concesión de RSU |
1,952,130 |
$1.94 |
$3.79M |
1,952,130 |
| 2025-01-24 |
Yoshiyama Annie |
SVP, Finance |
Concesión de RSU |
128,093 |
$1.94 |
$248.5K |
128,093 |
| 2025-01-24 |
Roberts Zachary |
EVP of R&d |
Concesión de RSU |
614,844 |
$1.94 |
$1.19M |
614,844 |
| 2025-01-21 |
Roberts Zachary |
EVP of R&d |
Venta Informativa |
27,199 |
$1.78 |
$48.41K |
488,054 |
| 2024-12-09 |
Messemer Deborah M. |
Director |
Venta Informativa |
9,136 |
$2.18 |
$19.92K |
157,629 |
| 2024-12-05 |
Humer Franz B |
Director |
Venta Informativa |
9,221 |
$2.16 |
$19.92K |
307,507 |
| 2024-10-21 |
Parker Geoffrey M. |
Chief Financial Officer |
Retención Fiscal de RSU |
36,404 |
$2.84 |
$103.39K |
1,131,988 |
| 2024-08-21 |
Douglas Earl Martin |
SVP, General Counsel |
Retención Fiscal de RSU |
28,310 |
$2.79 |
$78.84K |
449,324 |
| 2024-06-18 |
Messemer Deborah M. |
Director |
Venta Informativa |
18,641 |
$2.28 |
$42.49K |
166,765 |
| 2024-06-05 |
Sato Vicki L |
Director |
Concesión de RSU |
95,541 |
$2.44 |
$233.12K |
95,541 |
| 2024-06-05 |
Kazam Joshua A |
Director |
Concesión de RSU |
191,082 |
$2.44 |
$466.24K |
191,082 |
| 2024-06-05 |
Humer Franz B |
Director |
Concesión de RSU |
95,541 |
$2.44 |
$233.12K |
95,541 |
| 2024-06-05 |
Witte Owen N. |
Director |
Concesión de RSU |
191,082 |
$2.44 |
$466.24K |
191,082 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
